Authors/Disclosures
|
Anthony Traboulsee, MD
(University of British Columbia)
|
Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. The institution of Dr. Traboulsee has received research support from Roche. The institution of Dr. Traboulsee has received research support from Genzyme. |
|
Bernard M. Uitdehaag, MD, PhD, FAAN
(Amsterdam University Medical Centers)
|
Dr. Uitdehaag has nothing to disclose. |
|
|
No disclosure on file |
|
Ludwig Kappos, MD, FAAN
(RC2NB, University Hospital Basel)
|
The institution of Dr. Kappos has received research support from Bayer. The institution of Dr. Kappos has received research support from Biogen. The institution of Dr. Kappos has received research support from Genentech. The institution of Dr. Kappos has received research support from Genzyme. The institution of Dr. Kappos has received research support from Janssen. The institution of Dr. Kappos has received research support from Merck Serono. The institution of Dr. Kappos has received research support from Minoryx. The institution of Dr. Kappos has received research support from Novartis. The institution of Dr. Kappos has received research support from Roche. The institution of Dr. Kappos has received research support from Sanofi. The institution of Dr. Kappos has received research support from Santhera. The institution of Dr. Kappos has received research support from Swiss MS Society, Swiss National Research Foundation, European Union, Roche Research Foundation, Innosuisse. The institution of Dr. Kappos has received research support from Shionogi. The institution of Dr. Kappos has received research support from Japan Tobacco. The institution of Dr. Kappos has received research support from Auriga Vision AG. The institution of Dr. Kappos has received research support from EMD Serono. The institution of Dr. Kappos has received research support from Glaxo Smith Kline. The institution of Dr. Kappos has received research support from Wellmera AG. The institution of Dr. Kappos has received research support from Eli Lilly (Suisse) SA. The institution of Dr. Kappos has received research support from Bristol Myers Squibb. The institution of Dr. Kappos has received research support from Celltrion Inc. Dr. Kappos has received intellectual property interests from a discovery or technology relating to health care. |
|
Magnhild Sandberg-Wollheim, MD, PhD
(Dept of Neurology)
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Cris S. Constantinescu, MD, PhD
(Cooper Neurological Institute)
|
Dr. Constantinescu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Constantinescu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Constantinescu has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Novartis. The institution of Dr. Constantinescu has received research support from Nottingham University Hospital Charity. |
|
Elisabetta Verdun Di Cantogno, MD
(Merck Serono Int, SA)
|
Dr. Verdun Di Cantogno has received personal compensation for serving as an employee of EMD Serono Research & Development Institute, Inc., Billerica, MA, USA. Dr. Verdun Di Cantogno has stock in EMD Serono Research & Development Institute, Inc., Billerica, MA, USA. |
|
|
No disclosure on file |